跳至主要内容
临床试验/JPRN-UMIN000009615
JPRN-UMIN000009615已完成2 期

Feasibility study of stereotactic body radiotherapy for prostate cancer - Feasibility study of CyberKnife for prostate cancer

Radiation Oncology, Saitama Medical University, International Medical Center0 个研究点目标入组 20 人开始时间: 2012年12月24日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

The incidence of >grade 2 acute toxicity in all sites and that in the rectum after EHF-RT of 35 Gy in five fractions were 30% and 20%, respectively. High rectum-V28Gy was associated with grade 2 acute rectal toxicity after EHF-RT for early prostate cancer.

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 85years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) active double cancer(s) 2) Uncontrol DM 3) collagen disease, heart failure, sever respiratoy disease 4) Mental disease 5) Major operation of pelvic site 6) Surgery for prostate cancer 7) Chemotherapy for prostate cancer 8) Crohn's disease, Uncerlative colitis 9) Anti-coagulation agent 10) IPSS =<20 11) Artificial head

研究者

发起方
Radiation Oncology, Saitama Medical University, International Medical Center

相似试验